Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlos Flombaum

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|March 7, 2012
A retrospective observational study on the use of capecitabine in patients with severe renal impairment (GFR <30 mL/min) and end stage renal disease on hemodialysisKenar D Jhaveri, Carlos Flombaum, Manish Shah, et al.
Journal of the National Cancer Institute|August 18, 2005
Cetuximab therapy and symptomatic hypomagnesemiaDeborah Schrag, Ki Young Chung, Carlos Flombaum, et al.
Clinical Nephrology|November 16, 2020
Hypophosphatemia and FGF23 tumor-induced osteomalacia in two cases of metastatic breast cancerMatthew Abramson, Ilya G Glezerman, Maya Srinivasan, et al.
Cancer|April 28, 2004
High-dose calcitriol, zoledronate, and dexamethasone for the treatment of progressive prostate carcinomaMichael J Morris, Oren Smaletz, David Solit, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|March 7, 2012
A retrospective observational study on the use of capecitabine in patients with severe renal impairment (GFR <30 mL/min) and end stage renal disease on hemodialysisKenar D Jhaveri, Carlos Flombaum, Manish Shah, et al.
Journal of the National Cancer Institute|August 18, 2005
Cetuximab therapy and symptomatic hypomagnesemiaDeborah Schrag, Ki Young Chung, Carlos Flombaum, et al.
Clinical Nephrology|November 16, 2020
Hypophosphatemia and FGF23 tumor-induced osteomalacia in two cases of metastatic breast cancerMatthew Abramson, Ilya G Glezerman, Maya Srinivasan, et al.
Cancer|April 28, 2004
High-dose calcitriol, zoledronate, and dexamethasone for the treatment of progressive prostate carcinomaMichael J Morris, Oren Smaletz, David Solit, et al.
Pageof 1